Advertisement
U.S. markets closed

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.2100+0.0200 (+1.68%)
At close: 04:00PM EST
1.1500 -0.06 (-4.96%)
After hours: 08:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/20/2024
Current
9/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
84.30M484.94M733.88M543.70M1.05B
Enterprise Value
-18.45M365.63M563.68M326.81M802.96M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
3.8214.8922.4017.7342.80
Price/Book (mrq)
0.542.704.152.754.78
Enterprise Value/Revenue
-0.5939.39301.60129.28103.57
Enterprise Value/EBITDA
0.18-12.45-17.57-10.71-36.85

Trading Information

Stock Price History

Beta (5Y Monthly) 0.22
52-Week Change 3-90.72%
S&P500 52-Week Change 325.22%
52 Week High 313.2000
52 Week Low 30.5900
50-Day Moving Average 31.1158
200-Day Moving Average 35.7051

Share Statistics

Avg Vol (3 month) 32.64M
Avg Vol (10 day) 31.47M
Shares Outstanding 570.84M
Implied Shares Outstanding 670.84M
Float 849.93M
% Held by Insiders 12.65%
% Held by Institutions 196.24%
Shares Short (Jan 31, 2024) 46.33M
Short Ratio (Jan 31, 2024) 42.39
Short % of Float (Jan 31, 2024) 410.30%
Short % of Shares Outstanding (Jan 31, 2024) 48.94%
Shares Short (prior month Dec 29, 2023) 45.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sep 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-321.88%

Management Effectiveness

Return on Assets (ttm)-29.81%
Return on Equity (ttm)-60.94%

Income Statement

Revenue (ttm)21.43M
Revenue Per Share (ttm)0.31
Quarterly Revenue Growth (yoy)-51.20%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-114.62M
Diluted EPS (ttm)-1.6600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)103.05M
Total Cash Per Share (mrq)1.46
Total Debt (mrq)2.14M
Total Debt/Equity (mrq)1.37%
Current Ratio (mrq)4.51
Book Value Per Share (mrq)2.21

Cash Flow Statement

Operating Cash Flow (ttm)-90.68M
Levered Free Cash Flow (ttm)-52.01M